TRUVESIC Trademark

Trademark Overview

On Wednesday, December 4, 2024, a trademark application was filed for TRUVESIC with the United States Patent and Trademark Office. The USPTO has given the TRUVESIC trademark a serial number of 98884796. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 5, 2025. This trademark is owned by CG Oncology, Inc.. The TRUVESIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
truvesic

General Information

Serial Number98884796
Word MarkTRUVESIC
Filing DateWednesday, December 4, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, June 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 24, 2025

Trademark Statements

Description of MarkThe mark consists of the word "TRUVESIC" in a stylized font with the "V" in a sharp angled shape.
Goods and ServicesPharmaceutical products for the treatment of cancer, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCG Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Wednesday, December 4, 2024NEW APPLICATION ENTERED
Saturday, May 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 23, 2025ASSIGNED TO EXAMINER
Friday, May 23, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

truvesic treatment cancer pharmaceutical blood preparations namely antibodies factors products diagnostic